Citigroup
CALC icon

Citigroup’s CalciMedica CALC Stock Holding History

Citigroup’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,927
Closed -$15.2K – 6102
2025
Q3 		$15.2K Buy
+4,927
New +$14.2K ﹤0.01% 4902
2022
Q2 		– Sell
-2
Closed – – 6261
2022
Q1 		$0 Buy
+2
New +$38 ﹤0.01% 6324
2021
Q2 		– Sell
-31
Closed -$2K – 6140
2021
Q1 		$2K Sell
31
-56
-64% -$16.8K ﹤0.01% 6040
2020
Q4 		$35K Buy
+87
New +$25.7K ﹤0.01% 6280

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

Citigroup's CALC Position: Q4 2025 in Review

Citigroup sold out of CalciMedica (CALC) in Q4 2025, closing a stake of 4,927 shares — an estimated $15.2K sold.

Citigroup first reported a position in CALC in Q4 2020 and held it in 4 quarters. The position peaked at $35K in Q4 2020. 30 funds tracked by Wall St. Rank hold CALC as of Q4 2025.

  • Citigroup reported no remaining CalciMedica position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 4,927 CalciMedica shares in Q4 2025, an estimated $15.2K.
  • Citigroup first reported a position in CalciMedica in Q4 2020 and held it in 4 quarters.
  • Citigroup's CalciMedica position peaked at $35K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held CalciMedica as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.